Lifelong Learning: Double-Blind Placebo-Controlled Study of Memantine in Trichotillomania and Skin-Picking Disorder-View Article

View Article

Pdf Summary

This study investigates the use of memantine, a glutamate modulator, in treating trichotillomania (hair-pulling disorder) and skin-picking disorder. These are underrecognized conditions characterized by compulsive behaviors that lead to hair loss or skin damage. Despite their prevalence, effective treatments are limited, with therapy difficult to access and no specific FDA-approved medications.<br /><br />A total of 100 adults participated in the study, with a mean age of 31.4 years, 86 of whom were women. Participants received either memantine or placebo for eight weeks. The study used a variety of assessment tools to measure treatment outcomes, including the NIMH Trichotillomania Symptom Severity Scale, adapted to include skin picking, and the Clinical Global Impressions-Improvement scale.<br /><br />Results showed that memantine significantly reduced symptom severity in comparison to placebo, with 60.5% of participants in the memantine group reporting that they were "much or very much improved" by the study's end, versus just 8.3% in the placebo group. Notably, memantine was well-tolerated, with side effects similar to the placebo group mostly being mild, such as dizziness and fatigue.<br /><br />The study concluded that memantine could offer a promising pharmaceutical treatment option for compulsive behaviors associated with trichotillomania and skin-picking disorder, thanks to its modulation of the glutamate system, which is implicated in these disorders. These findings suggest memantine as a potent alternative or adjunct to behavioral therapy for managing these conditions, although longer-term studies and further exploration of dosage efficacy are recommended.<br /><br />Overall, this research supports the potential for memantine to serve as a novel treatment avenue for these challenging and often debilitating psychiatric disorders, paving the way for more comprehensive care options in clinical settings.

Keywords

memantine

glutamate modulator

trichotillomania

skin-picking disorder

compulsive behaviors

clinical study

psychiatric disorders

treatment outcomes

symptom severity

behavioral therapy